Biological Therapy Analysis & Statistics, May 2011 (p20)

24/7 Customer Support

Talk to Clare

+44 20 8144 3147

571-600 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

Cord Blood, Embryonic and Adult Stem Cells Applications & Technologies - A Global Market Watch, 2009-2015

Cord Blood, Embryonic and Adult Stem Cells Applications & Technologies - A Global Market Watch, 2009-2015

  • € 3 768
  • Industry report
  • May 2011
  • by Axis Research Mind

REPORT DESCRIPTION GLOBAL MARKET WATCH Global stem cells market is forecasts to reach US$63.8 billion by 2015 from an estimated value of US$21.5 billion in 2010, exhibiting a triple fold growth rate during ...

  • Industries : Biological Therapy
  • Countries : World, Europe, Asia
Cryopreservation Equipments in Stem Cells - A Global Market Watch, 2009-2015

Cryopreservation Equipments in Stem Cells - A Global Market Watch, 2009-2015

  • € 2 832
  • Industry report
  • May 2011
  • by Axis Research Mind

REPORT DESCRIPTION Global Market Watch With a CAGR of 23.7%, global market value for cryopreservation equipments used in stem cells industry is anticipated to worth US$2.2 billion by 2015. On a global ...

  • Industries : Biological Therapy, Blood Supply, Tissue Banking and Transplantation
  • Countries : World, Europe, Asia
Cancer Vaccines Markets

Cancer Vaccines Markets

  • € 2 720
  • Industry report
  • May 2011
  • by TriMark Publications

Cancer vaccines have the potential to become a significant force in future cancer treatments. In 2010, Dendreon's Provenge became the first cancer vaccine approved by the FDA, generating renewed interest ...

  • Industries : Biopharmaceutical, Drug and Medication, Pharmaceutical, Pathology, Biotechnology
  • Countries : United States
US Stem Cell Market Analysis

US Stem Cell Market Analysis

  • € 640
  • Industry report
  • April 2011
  • by RNCOS

The stem cell market has been growing at a fast pace for the past few years and despite recession, the US continued to witness positive developments and massive investments in this industry. Using stem ...

  • Industries : Biological Therapy
  • Countries : United States
RNAi for Therapeutic Applications Market Prospects 2011-2021

RNAi for Therapeutic Applications Market Prospects 2011-2021

  • € 1 889
  • Industry report
  • March 2011
  • by Visiongain

How will the RNA interference (RNAi) therapies market develop this decade? Our new report shows you that emerging market's revenue potential from 2011 to 2021. You will see the commercial prospects fo ...

  • Industries : Biological Therapy
Competitor Analysis RNA Therapeutics in Clinical Development

Competitor Analysis RNA Therapeutics in Clinical Development

  • € 400
  • Industry report
  • March 2011
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about RNA Therapeutics in Clinical Development provides a competitor evaluation in the field of RNA based molecules being developed in clinical ...

  • Industries : Genomics, Biotechnology, Biological Therapy
Stem Cell Therapeutics for Oncology: Technologies and Global Markets

Stem Cell Therapeutics for Oncology: Technologies and Global Markets

  • € 5 320
  • Industry report
  • March 2011
  • by BCC Research

The global stem cell anticancer therapeutics market was valued at $859 million in 2010. This market is expected to increase at an 11.3% compound annual growth rate (CAGR) to reach nearly $1.5 billion in ...

  • Industries : Pathology, Therapy, Biological Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Molecular Diagnostics: Double-Digit Growth Anticipated

Molecular Diagnostics: Double-Digit Growth Anticipated

  • € 2 556
  • Industry report
  • February 2011
  • by CHI Insight Pharma Reports

Industry-leading growth rates, expanding applications and innovation characterize the molecular diagnostics sector. This report presents a synthesis of these developments including the increased diversity ...

  • Industries : Diagnostics, Diagnostics, In Vitro Diagnostic, In Vitro Diagnostic
Competitor Analysis Interferon

Competitor Analysis Interferon

  • € 450
  • Industry report
  • February 2011
  • by La Merie Publishing

Product description The Competitive Intelligence Report Interferon as of February 2011 provides a competitor analysis in the development pipeline of novel recombinant and natural interferon alpha, beta, ...

  • Industries : Biological Therapy
US Stem Cells Research Industry

US Stem Cells Research Industry

  • € 3 600
  • Industry report
  • February 2011
  • by Global Industry Analysts

This report analyzes the US Market for Stem Cells Research in US$ Million. Annual forecasts are provided for the period 2006 through 2015. The report profiles 92 companies including many key and niche ...

  • Industries : Biological Therapy
Cell-Based Assays for Drug Discovery

Cell-Based Assays for Drug Discovery

  • € 2 720
  • Industry report
  • January 2011
  • by TriMark Publications

The area of drug discovery tools is one of the newest and most important sectors of pharmaceutical research and development. The term drug discovery tools usually refers to high-content screening (HCS) ...

  • Industries : Drug Discovery and Development, Biotechnology, Genomics
Pharmaceutical Bundle

Pharmaceutical Bundle

  • € 23 935
  • Industry report
  • January 2011
  • by TriMark Publications

The Pharmaceutical Bundle includes the following reports (the individual reports being purchased separately): -Molecular Diagnostics in Cancer Testing -Molecular Diagnostics in Infectious Disease Testing ...

  • Industries : In Vitro Diagnostic, In Vitro Diagnostic
Competitor Analysis G-CSF & GM-CSF

Competitor Analysis G-CSF & GM-CSF

  • € 350
  • Industry report
  • January 2011
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about G-CSF & GM-CSF products in the pipeline and off-patent products provides a competitor evaluation in the field of G-CSF & GM-CSF branded ...

  • Industries : Biological Therapy
Amgen: Pipeline • Products • Performance • Potential

Amgen: Pipeline • Products • Performance • Potential

  • € 744
  • Company report
  • November 2010
  • by Espicom Business Intelligence

Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance ...

  • Countries : Europe, United Kingdom
Stem Cell News

Stem Cell News

  • € 494
  • Industry report
  • November 2010
  • by Espicom Business Intelligence

These days we all suffer from information overload. To overcome this problem, the Stem Cell News service focuses specifically on stem cell research, delivering the information you need in a timely, flexible ...

  • Industries : Biotechnology, Biological Therapy, Pathology
RNAi: Product Usage and Brand Assessment

RNAi: Product Usage and Brand Assessment

  • € 1 536
  • Industry report
  • October 2010
  • by BioInformatics

As scientists gain a greater understanding of RNAi capabilities and limitations, and as the RNAi market continues to grow rapidly, more varied RNAi products and selections are becoming commercially available. ...

  • Industries : Biological Therapy
IP Overview – “Monoclonal Antibodies against digestive system cancers” Patent Landscape 2010

IP Overview – “Monoclonal Antibodies against digestive system cancers” Patent Landscape 2010

  • € 3 000
  • Industry report
  • September 2010
  • by France Innovation Scientifique et Transfert

In order to fight digestive system cancers, monoclonal antibody-based therapies have recently reinforced the range of already marketed treatments (mostly constituted of small molecules) and are generating ...

  • Industries : Biological Therapy
Human Embryonic Stem Cells (hESC) - A Global Market Overview

Human Embryonic Stem Cells (hESC) - A Global Market Overview

  • € 3 744
  • Industry report
  • July 2010
  • by Industry Experts

`Embryonic stem cell (hESC) research has attracted a lot of attention the world over and the controversy surrounding it just does not seem to die down. Stem cells are unspecialized cells that are capable ...

  • Industries : Biotechnology, Biological Therapy
  • Countries : World, Europe, Asia, North America
Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets

Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets

  • € 8 000
  • Industry report
  • July 2010
  • by Frost & Sullivan

The primary objective of this study is to measure brand perceptions of tools and technologies currently at the forefront of stem cell research. Stem cell researchers' preferences are assessed for five ...

  • Industries : Biotechnology, IT Services, IT Services, Biological Therapy, Genomics
Stem Cells Market And Drug Discovery Applications, 2009-2015

Stem Cells Market And Drug Discovery Applications, 2009-2015

  • € 3 026
  • Industry report
  • July 2010
  • by Axis Research Mind

The ‘Stem Cells Market and Drug Discovery applications, 2009-2015’ reviews latest Stem Cells market trends with a perceptive to disclose the near-future growth prospects. An in-depth analysis across ...

  • Industries : Biotechnology, Biological Therapy
  • Countries : World, Asia, Europe, North America
Stem Cells Market And Technologies, 2009-2015

Stem Cells Market And Technologies, 2009-2015

  • € 3 480
  • Industry report
  • July 2010
  • by Axis Research Mind

The ‘Stem Cells Market and Technologies: (2009-2015)’ reviews the latest trends in the stem cells market with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis ...

  • Industries : Biotechnology, Biological Therapy
  • Countries : World, Europe, Asia, North America
Stem Cells Market And Applications. 2009-2015

Stem Cells Market And Applications. 2009-2015

  • € 3 818
  • Industry report
  • July 2010
  • by Axis Research Mind

REPORT DESCRIPTION The ‘Stem Cells Market and Applications: (2009-2015)’ reviews the latest Stem Cells market trends with a perceptive to disclose the near-future growth prospects. An in-depth analysis ...

  • Industries : Biotechnology, Biological Therapy
  • Countries : World, Asia, Europe, North America
Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025

Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025

  • € 1 889
  • Industry report
  • June 2010
  • by Visiongain

In 2009, monoclonal antibodies for cancer therapy generated total revenues of over $18bn worldwide. From 2010, that sector will benefit from new drugs and expanding indications for existing products. Cance ...

  • Industries : Biopharmaceutical, Diagnostics, Diagnostics, Biological Therapy, In Vitro Diagnostic, In Vitro Diagnostic, Biotechnology
  • Countries : World
Stem Cells - The Hype and the Hope 2010-2025

Stem Cells - The Hype and the Hope 2010-2025

  • € 1 889
  • Industry report
  • May 2010
  • by Visiongain

Report Details - what commercial prospects for those technologies in medicine? In 2010, the stem cells market stands on the brink of technological and commercial breakthroughs, our new study explains. ...

  • Industries : Biological Therapy
Advances in Stem Cells (Technical Insights)

Advances in Stem Cells (Technical Insights)

  • € 5 200
  • Industry report
  • December 2009
  • by Frost & Sullivan

This report details the developments in adult, embryonic and induced pluripotent stem cells.

  • Industries : Biological Therapy
Advances in RNAi (Technical Insights)

Advances in RNAi (Technical Insights)

  • € 5 200
  • Industry report
  • December 2009
  • by Frost & Sullivan

This research service outlines the key global developments in the field of RNAi.

  • Industries : Biotechnology, Biological Therapy
  • Countries : World
U.S. Brachytherapy Market

U.S. Brachytherapy Market

  • € 4 800
  • Industry report
  • December 2009
  • by Frost & Sullivan

This research service looks at the seeds brachytherapy market.  

  • Industries : Therapy, General Medicine and Specialty Medicine, Pathology
  • Countries : United States
Competitor Analysis FGF-R Agonists and Antagonists

Competitor Analysis FGF-R Agonists and Antagonists

  • € 300
  • Industry report
  • November 2009
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about FGF-R agonists and antagonists provides a competitor evaluation in the field of fibroblast growth factor receptor (FGF-R) or PDGF targeting ...

  • Industries : Pharmaceutical, Biological Therapy, Biotechnology
Competitor Analysis CXCR and CXCL Agonists and Antagonists

Competitor Analysis CXCR and CXCL Agonists and Antagonists

  • € 300
  • Company report
  • November 2009
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about CXCR agonists and CXCR/CXCL antagonists provides a competitor evaluation in the field of chemokine receptor CXCR or its ligands CXCL ...

  • Industries : Pharmaceutical, Biological Therapy, Pathology
Immunotherapies and Vaccines for Nontraditional Indications

Immunotherapies and Vaccines for Nontraditional Indications

  • € 2 396
  • Industry report
  • October 2009
  • by CHI Insight Pharma Reports

Novel applications of immunotherapies and vaccines beyond prevention and treatment of infectious diseases and cancer are reviewed. Those discussed typically target molecules not normally targeted by the ...

  • Industries : Pharmaceutical, Pathology

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.